- Report
- February 2021
- 56 Pages
Global
€1274EUR$1,318USD£1,094GBP
Adzenys XR is a brand of extended-release medication used to treat attention deficit hyperactivity disorder (ADHD) in adults and children aged 6 and older. It is a central nervous system stimulant that works by increasing the amount of certain natural substances in the brain that are responsible for controlling behavior and attention. Adzenys XR is a once-daily, orally-disintegrating tablet that is taken with or without food. It is available in three strengths: 3.1 mg, 6.3 mg, and 9.4 mg.
Adzenys XR is part of a larger market of mental disorder drugs, which includes medications used to treat depression, anxiety, bipolar disorder, and schizophrenia. These drugs are typically prescribed by psychiatrists and other mental health professionals.
The Adzenys XR market is highly competitive, with several major pharmaceutical companies offering similar products. These include Shire, Johnson & Johnson, Pfizer, and Novartis. Other companies in the market include Mylan, Impax Laboratories, and Teva Pharmaceuticals. Show Less Read more